Clinical Trials Browser

Phase 1 × Fallopian Tube Neoplasms × durvalumab × Clear all

NCT03283943 2018-07-11

PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.

Phase 1 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms